Drug recall · December 18, 2019
25% Dextrose Injection recall
Why: Labeling: Incorrect or Missing Lot and/or expiration date.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
- Lots / codes
Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.
- Quantity
- 77,100 syringes
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide within the United States including Puerto Rico.
- Initiated
- November 27, 2019 · Voluntary: Firm initiated
- Classified
- December 6, 2019
- Reported
- December 18, 2019
- Ended
- January 14, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glucose
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.